[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CY1124160T1 - Ενα τροποποιημενο κολλαγονο - Google Patents

Ενα τροποποιημενο κολλαγονο

Info

Publication number
CY1124160T1
CY1124160T1 CY20211100346T CY211100346T CY1124160T1 CY 1124160 T1 CY1124160 T1 CY 1124160T1 CY 20211100346 T CY20211100346 T CY 20211100346T CY 211100346 T CY211100346 T CY 211100346T CY 1124160 T1 CY1124160 T1 CY 1124160T1
Authority
CY
Cyprus
Prior art keywords
collagen
modified collagen
modified
isolated
maturing
Prior art date
Application number
CY20211100346T
Other languages
English (en)
Inventor
Michael Myers
Alexandra DIETRICH
Original Assignee
Innocoll Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20120150527 external-priority patent/EP2612888A1/en
Priority claimed from GBGB1220868.2A external-priority patent/GB201220868D0/en
Application filed by Innocoll Pharmaceuticals Limited filed Critical Innocoll Pharmaceuticals Limited
Publication of CY1124160T1 publication Critical patent/CY1124160T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L89/00—Compositions of proteins; Compositions of derivatives thereof
    • C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
    • C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με ένα τροποποιημένο κολλαγόνο το οποίο μπορεί να ληφθεί με παροχή απομονωμένου κολλαγόνου• κατάψυξη του απομονωμένου κολλαγόνου• αφυδάτωση του κατεψυγμένου κολλαγόνου• και ωρίμανση του αφυδατωμένου κολλαγόνου. Επίσης γνωστοποιούνται μέθοδοι παρασκευής του τροποποιημένου κολλαγόνου και χρήσεις αυτού.
CY20211100346T 2012-01-09 2021-04-21 Ενα τροποποιημενο κολλαγονο CY1124160T1 (el)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP20120150527 EP2612888A1 (en) 2012-01-09 2012-01-09 A modified collagen
GBGB1220868.2A GB201220868D0 (en) 2012-11-20 2012-11-20 A modified collagen
PCT/EP2013/050333 WO2013104687A2 (en) 2012-01-09 2013-01-09 A modified collagen
EP13700286.1A EP2802624B1 (en) 2012-01-09 2013-01-09 A modified collagen
EP17181156.5A EP3255106B1 (en) 2012-01-09 2013-01-09 A modified collagen

Publications (1)

Publication Number Publication Date
CY1124160T1 true CY1124160T1 (el) 2022-05-27

Family

ID=47559477

Family Applications (3)

Application Number Title Priority Date Filing Date
CY20171101134T CY1119524T1 (el) 2012-01-09 2017-10-31 Ena τροποποιημενο κολλαγονο
CY20191100545T CY1121643T1 (el) 2012-01-09 2019-05-22 Ενα τροποποιημενο κολλαγονο
CY20211100346T CY1124160T1 (el) 2012-01-09 2021-04-21 Ενα τροποποιημενο κολλαγονο

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CY20171101134T CY1119524T1 (el) 2012-01-09 2017-10-31 Ena τροποποιημενο κολλαγονο
CY20191100545T CY1121643T1 (el) 2012-01-09 2019-05-22 Ενα τροποποιημενο κολλαγονο

Country Status (21)

Country Link
US (4) US10487134B2 (el)
EP (4) EP3901218A1 (el)
JP (3) JP6494285B2 (el)
AU (1) AU2013208952B2 (el)
CA (1) CA2860552C (el)
CY (3) CY1119524T1 (el)
DK (3) DK3536748T3 (el)
EA (2) EA027745B1 (el)
ES (3) ES2645445T3 (el)
HK (1) HK1244296B (el)
HR (3) HRP20171635T1 (el)
HU (3) HUE054838T2 (el)
LT (3) LT3255106T (el)
MX (1) MX368037B (el)
NO (1) NO2802624T3 (el)
PL (3) PL2802624T3 (el)
PT (2) PT3255106T (el)
RS (3) RS56564B1 (el)
SI (3) SI2802624T1 (el)
TR (1) TR201907156T4 (el)
WO (1) WO2013104687A2 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2802624T3 (el) * 2012-01-09 2017-12-30
US20180237259A1 (en) * 2017-02-22 2018-08-23 Otis Elevator Company Method for detecting trapped passengers in elevator car
RU2704248C1 (ru) * 2018-10-02 2019-10-25 Федеральное государственное бюджетное образовательное учреждение высшего образования "Воронежский государственный университет инженерных технологий" (ФГБОУ ВО "ВГУИТ") Способ получения пористого коллагенового материала
RU2760326C1 (ru) * 2021-03-04 2021-11-24 Общество с ограниченной ответственностью научно-производственное объединение «Велис» Способ получения пористого влагоемкого материала на коллагеновой основе
US20240226382A1 (en) 2021-04-12 2024-07-11 Innocoll Pharmaceuticals Limited Drug-release implant for laparoscopic surgery
CN113201569B (zh) * 2021-06-21 2022-08-30 江南大学 一种牛ⅰ型胶原蛋白的纯化方法
EP4376806A2 (en) * 2021-07-28 2024-06-05 Innocoll Pharmaceuticals Limited Bupivacaine-collagen drug delivery implant and methods of making and using thereof
WO2023084005A1 (en) * 2021-11-12 2023-05-19 Innocoll Pharmaceuticals Limited Resorbable collagen scaffold for dural repair
WO2024079289A1 (en) 2022-10-12 2024-04-18 Innocoll Pharmaceuticals Limited A kit for implanting a drug-release implant for laparoscopic surgery

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5246282B2 (el) * 1972-11-15 1977-11-24
US4097234A (en) * 1976-12-10 1978-06-27 Nippi, Incorporated Method for preparing dispersion of collagen fiber
US4279812A (en) 1979-09-12 1981-07-21 Seton Company Process for preparing macromolecular biologically active collagen
US5206028A (en) 1991-02-11 1993-04-27 Li Shu Tung Dense collagen membrane matrices for medical uses
FR2720945B1 (fr) 1994-06-08 1996-08-30 Coletica Membrane collagénique anti-adhérence post-opératoire.
US5945125A (en) 1995-02-28 1999-08-31 Temple University Controlled release tablet
WO1998031403A1 (en) * 1997-01-16 1998-07-23 Cohesion Corporation Lyophilized collagen-based biomaterials, process of preparation and uses thereof
US20010014667A1 (en) * 1998-01-05 2001-08-16 Chen Charles C. Compositions with enhanced osteogenic potential, methods for making the same and therapeutic uses thereof
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
GB2345638A (en) * 1998-09-11 2000-07-19 Tissue Science Lab Limited Injectable collagen compositions
US6682760B2 (en) * 2000-04-18 2004-01-27 Colbar R&D Ltd. Cross-linked collagen matrices and methods for their preparation
EP2314293B1 (en) 2001-01-16 2017-01-04 Vascular Therapies, LLC Implantable device containing resorbable matrix material and rapamycin for preventing or treating vasuloproliferative diseases
US7098315B2 (en) * 2001-01-25 2006-08-29 Nycomed Pharma As Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
JP2004099513A (ja) * 2002-09-09 2004-04-02 Toshiba Corp クラゲのコラーゲン回収方法及びクラゲのコラーゲン回収システム
WO2004090151A2 (en) * 2003-04-11 2004-10-21 Ecodynamic Biolab Inc. Method for extracting collagen comprising microbial fermentation
US7534422B2 (en) * 2004-07-09 2009-05-19 Viscofan, S.A. Universal fishing bait based on fibrous collagen and the procedure for its preparation
USRE47826E1 (en) * 2007-03-28 2020-01-28 Innocoll Pharmaceuticals Limited Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
US8034368B2 (en) * 2007-03-28 2011-10-11 Innocoll Technologies Limited Drug delivery device for providing local analgesia, local anesthesia or nerve blockage
PL3085363T3 (pl) 2007-03-28 2019-08-30 Innocoll Pharmaceuticals Limited Urządzenie dostarczające lek dla zapewnienia miejscowej analgezji, miejscowego znieczulenia lub blokady nerwowej
US7820794B2 (en) 2008-09-11 2010-10-26 Sunmax Biotechnology Co., Ltd. Long-lasting collagen and manufacturing method thereof
IES20090859A2 (en) * 2008-11-06 2010-06-23 Innocoll Technologies Ltd Drug delivery implants and processes for their preparation
EP2459011B1 (en) * 2009-07-27 2016-04-13 National Cheng Kung University Preparation of high purity collagen
JP2011225462A (ja) * 2010-04-16 2011-11-10 Ihara Suisan Kk 多孔質コラーゲン、その製造方法およびその用途
US8951598B2 (en) 2010-05-07 2015-02-10 Empire Technology Development Llc Nanoscale collagen particles and membranes
EP2510929A1 (en) * 2011-04-11 2012-10-17 Innocoll Technologies Limited Methods for treating bacterial infection
NO2802624T3 (el) * 2012-01-09 2017-12-30
US11623947B2 (en) * 2013-04-08 2023-04-11 Innocoll Pharmaceuticals Limited Collagen powder

Also Published As

Publication number Publication date
TR201907156T4 (tr) 2019-06-21
PT3255106T (pt) 2019-06-04
HUE043826T2 (hu) 2019-09-30
EA201790763A2 (ru) 2017-07-31
NO2802624T3 (el) 2017-12-30
LT3255106T (lt) 2019-07-25
JP6494285B2 (ja) 2019-04-03
WO2013104687A3 (en) 2013-12-05
US20170022266A1 (en) 2017-01-26
SI2802624T1 (en) 2018-02-28
JP2019065017A (ja) 2019-04-25
EP3536748A1 (en) 2019-09-11
PL3536748T3 (pl) 2021-07-19
ES2870137T3 (es) 2021-10-26
EP3536748B1 (en) 2021-02-24
US20190359689A1 (en) 2019-11-28
DK2802624T3 (da) 2017-11-13
HRP20210699T1 (hr) 2021-09-17
US20150011476A1 (en) 2015-01-08
PL3255106T3 (pl) 2019-09-30
CA2860552A1 (en) 2013-07-18
US20220213173A1 (en) 2022-07-07
LT2802624T (lt) 2017-12-27
HRP20171635T1 (hr) 2018-02-23
DK3255106T3 (da) 2019-05-20
MX368037B (es) 2019-09-17
HUE037043T2 (hu) 2018-08-28
JP2015508403A (ja) 2015-03-19
JP2020169188A (ja) 2020-10-15
PT2802624T (pt) 2017-11-10
RS61726B1 (sr) 2021-05-31
EA037396B1 (ru) 2021-03-24
EP3901218A1 (en) 2021-10-27
EP3255106B1 (en) 2019-04-24
AU2013208952B2 (en) 2016-09-15
PL2802624T3 (pl) 2018-02-28
CY1119524T1 (el) 2018-03-07
CA2860552C (en) 2020-06-16
DK3536748T3 (da) 2021-05-03
AU2013208952A1 (en) 2014-08-28
MX2014008327A (es) 2015-05-11
RS58935B1 (sr) 2019-08-30
US11746141B2 (en) 2023-09-05
SI3536748T1 (sl) 2021-08-31
HRP20190861T1 (hr) 2019-08-09
WO2013104687A2 (en) 2013-07-18
RS56564B1 (sr) 2018-02-28
JP6720279B2 (ja) 2020-07-08
EA027745B1 (ru) 2017-08-31
ES2728205T3 (es) 2019-10-22
EP3255106A1 (en) 2017-12-13
EA201491278A1 (ru) 2015-01-30
EP2802624B1 (en) 2017-08-02
ES2645445T3 (es) 2017-12-05
SI3255106T1 (sl) 2019-09-30
EP2802624A2 (en) 2014-11-19
LT3536748T (lt) 2021-08-10
HUE054838T2 (hu) 2021-10-28
JP7213205B2 (ja) 2023-01-26
US10487134B2 (en) 2019-11-26
HK1244296B (zh) 2020-06-05
CY1121643T1 (el) 2020-07-31
EA201790763A3 (ru) 2017-11-30

Similar Documents

Publication Publication Date Title
CY1124160T1 (el) Ενα τροποποιημενο κολλαγονο
CY1123958T1 (el) Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης
CY1121862T1 (el) Αντισωματα anti-phf-tau και χρησεις αυτων
CY1117956T1 (el) N3-αντικατεστημενα-n1-sulfonyl-5-fluoropyrimidinone παραγωγα
EA202092987A3 (ru) Липид, содержащий докозапентаеновую кислоту
SG11201501968VA (en) Method for preparing imp fermented broth or glutamic acid fermented broth as raw material for preparation of natural flavor
UY34660A (es) Inhibidores de benzodioxano de la producción de leucotrieno
SMT201500208B (it) Derivati di piridinone come inibitori della transglutaminasi tissutale
IL244949A0 (en) Natural fermentation of frozen dairy desserts using a natural plant source
CY1120759T1 (el) Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης
EA201290623A1 (ru) Лактобациллы с антиоксидантным действием
EA201600026A1 (ru) Бактериальная гиалуронидаза и способ ее производства
MX2015009938A (es) Macromoleculas en forma de estrella tolerantes a las sales.
UY36443A (es) Fibras de polipropileno mejoradas, métodos para su producción y usos de estas para la producción de productos de fibrocemento
BR112014000460A2 (pt) método para produzir alimento seco
CY1121067T1 (el) Εμβολιο πεπτιδιου pcsk9
EA201690857A1 (ru) Конъюгатные вакцины на основе сальмонеллы
EA201690793A1 (ru) Способ получения лиофилизированной фармацевтической композиции, содержащей митомицин c
TR201905819T4 (tr) Paketlenmiş tütünün pastörize edilmesi.
EP2994483A4 (en) Methods and compositions related to large scale production of proteins
BR112015022234A2 (pt) nanopartículas de lípidos sólidos (ii)
BR112015022233A2 (pt) nanopartículas de lípidos sólidos
IN2013MU01290A (el)
CO7151534A2 (es) Endoglucanasas con propiedades mejoradas
AR090964A1 (es) Proceso para la elaboracion de undecapeptidos ciclicos